Skip to main content
Sharad Khurana, MD, Hematology, Tucson, AZ

SharadKhuranaMDMSc

Hematology Tucson, AZ

Hematologic Oncology

Assistant Professor of Medicine

Dr. Khurana is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Khurana's full profile

Already have an account?

  • Office

    University of Arizona Cancer Center - North Campus
    3838 N Campbell Ave
    Tucson, AZ 85719

Summary

  • Bone Marrow Transplant/Cellular Therapist with focus on Acute myeloid/lymphoid Leukemias and myeloid disorders.

Education & Training

  • Mayo Clinic College of Medicine and Science (Jacksonville)
    Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2017 - 2020
  • Rush University
    Rush UniversityMSc, Clinical Research, 2015 - 2017
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2014 - 2017
  • Grant Medical College
    Grant Medical CollegeClass of 2013

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2020 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2021
  • IL State Medical License
    IL State Medical License 2014 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Incidence and Outcomes of Cardiovascular Disease in Hemophilia Patients: An Analysis of National Inpatient Sample Database
    Sharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...
    Sharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships